Herein, we demonstrated that E2F8 upregulates the EMT and Notch signaling pathways, and a further follow-up study is being planned to support the hypothesis that E2F8 promotes ovarian cancer progression by upregulating multiple cell cycle regulators. This evidence concerns the gene E2F8 and ovarian carcinoma.